2020 GLOBAL FINALIST
EluciData
Digital Health Covid-19
EluciData’s mission is to break barriers to using biomedical data to discover better drugs, faster in order to create a future in which data and information transform and accelerate biomedical discovery and improve health and health care. The company’s AI-enabled cloud-based platform, Polly, provides teams with access to structured biomedical data in a ready-to-use form to generate actionable insights.
💸 Select investors: Hyperplane Venture Capital, IvyCap Ventures, WhiteHill Ventures
📌 HQ: Cambridge, Massachusetts, United States